United States · FDA National Drug Code directory
Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-113_7337a732-33b5-45d0-b460-0afcdf3a60a3
- Product NDC
- 65862-113
- Form
- CAPSULE
- Composition / generic term
- Hydrochlorothiazide
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070919
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (65862-113-01) · 65862-113-01
- 500 CAPSULE in 1 BOTTLE (65862-113-05) · 65862-113-05
- 300 CAPSULE in 1 BOTTLE (65862-113-33) · 65862-113-33
- 1000 CAPSULE in 1 BOTTLE (65862-113-99) · 65862-113-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →